Profound hyperacute cardiac allograft rejection rescue with biventricular mechanical circulatory support and plasmapheresis, intravenous immunoglobulin, and rituximab therapy
Open Access
- 16 March 2013
- journal article
- case report
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 8 (1) , 48
Abstract
Hyperacute rejection is a rare but potentially catastrophic complication after cardiac transplantation. We describe an unusual case of hyperacute rejection due to preformed anti-donor antibodies despite a negative preoperative panel-reactive antibody (PRA) screen. An excellent outcome was achieved in this case and our strategy involving the use of CentriMag ventricular assist devices (VADs) for biventricular support during treatment with rituximab, intravenous immunoglobulin (IVIG), and plasmapheresis is illustrated.Keywords
This publication has 7 references indexed in Scilit:
- Transplantation of High Panel-Reactive Antibody Left Ventricular Assist Device Patients Without Crossmatch Using On-Bypass Pheresis and AlemtuzumabThe Annals of Thoracic Surgery, 2011
- Successful Treatment of Cardiogenic Shock Caused by Humoral Cardiac Allograft RejectionCirculation Journal, 2009
- Influence of Pretransplant Panel-Reactive Antibody on Outcomes in 8,160 Heart Transplant Recipients in Recent EraThe Annals of Thoracic Surgery, 2007
- Successful Management of Antibody-Mediated Cardiac Allograft Rejection With Combined Immunoadsorption and Anti-CD20 Monoclonal Antibody Treatment: Case Report and Literature ReviewThe Journal of Heart and Lung Transplantation, 2007
- Panel-reactive antibody screening practices prior to heart transplantationThe Journal of Heart and Lung Transplantation, 2002
- FLOW CYTOMETRIC DETECTION OF HLA-SPECIFIC ANTIBODIES AS A PREDICTOR OF HEART ALLOGRAFT REJECTION1Transplantation, 2000
- Hyperacute rejection of a transplanted human heart.1981